fbpx

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Monday’s Markets See Nasdaq & S&P Large Tech Plays Lead – $AAPL $AFRM $GSAT $INMB $PYPL $TSLA Charge Higher

By John F. Heerdink, Jr.
Markets See Nasdaq & S&P Large Tech Plays Lead
“By failing to prepare, you are preparing to fail.” – Benjamin Franklin, Lived: January 17, 1706 – April 17, 1790


Happy Monday!

I hope that you all had a great day & that the majority of your investments were in the Nasdaq & S&P 500 as they led the way again today. Tech giants/highly weighted names, in particular, stole the show today i.e. Apple (AAPl, $153.12, +3%), Amazon.com (AMZN, $3421.57, +2.2%) Microsoft (MSFT, $303.59, +1.3%) & Tesla (TSLA, $730.91, +2.67%) all move moved up significantly and a small biotech and VP Watchlist stock INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease including Alzheimer’s disease, closed at $22.60,  up a solid +12.83% after hitting $23.76 in intraday trading, as a short squeeze of sort was rumored to be playing out. Dow 30 component Cisco (CSCO) closed at $59.13, +.19% & chip giant NVIDIA (NVDA) closed at $226.88, +.23% after establishing a new all-time high of $230.43 again this week. Shares of PayPal (PYPL) closed at $288.47, +3.64% after stories surfaced that they are exploring the oportunity of adding a stock trading platform. Who knew that it was so sexy to get involved in the brokerage industry again, especially after squashing the commission schedule to $0? Affirm (AFRM) charged up to close at $99.59,  +46.7% after Friday’s announcement of their partnership with Amazon (AMZN) to bring Affirm’s ‘buy-now, pay-later’ or ‘BNPL’ service to Amazon’s customers further spread though the world. Affirm’s website states “When you buy with Affirm, you always know exactly what you’ll owe and when you’ll be done paying. There are no hidden fees—not even late fees.”

The large cap indices closed as follows: the S&P 500 closed at 4,528.79 (+.43%) as the real estate sector moved up 1.2% & the information technology sector moved up 1.1% to lead the advance, while the cyclical oriented sectors including the financials that moved down 1.5% & the energy sector that moved down 1.2% added a sufficient drag on the markets, the Dow 30 closed at 35,399.84 (-.16%), & the Nasdaq closed at 15,265.89 (+.90%). The small caps on the Russell 2000 pulled back again as the index ended at 2,265.99 (-.49%). The MicroCaps also moved lower as the iShares Micro-Cap ETF (IWC) closed at $147.77, (-.85%).  

The macroeconomic schedule delivered the Pending Home Sales report that confirmed a drop by 1.8% month/month in July. Tomorrow’s schedule will produce the Conference Board’s Consumer Confidence Index report for August, the Chicago PMI report for August, the FHFA Housing Price Index report for June, & the S&P Case-Shiller Home Price Index report for June on Tuesday.

The yield curve moved lower, as the 10-yr treasury yield fell 3 basis points closing at 1.29% as did the 2-yr yield that dropped 2 basis points to close at .20%. The U.S. Dollar Index closed at 92.65.

Gold prices moved lower by $7 to close at $1,812 and silver closed at $24.06, -$.01.

Oil prices closed higher at $69.21/bbl bumping up .6% prior to the next OPEC+ meeting scheduled for Wednesday and in light of Hurricane Ida’s temporary shutdown of oil refineries in the Gulf. 

MIXED BIOTECH

The SPDR S&P Biotech ETF (XBI) closed at $131.63, -.30%, the iShares Nasdaq Biotechnology ETF (IBB) closed at $171.99, +.10% & the NYSE ARCA Biotech Index (^BTK) closed at 5,929.92, -.16%. 


MEMES WATCH

AMC Entertainment (AMC) closed at $43.33, +6.10% & GameStop (GME) also closed at $209.20, +2.07%.

Best Buy (BBY) closed at $118.35,  +.72%. They beat wall street’s expectations last week as they produced earnings of $2.98 vs $1.91 & revs at $11.85B, +20% Y/Y. 

Shares of infamous ‘meme brokerage’ firm Robinhood Markets, Inc., (HOOD) closed at $43.64, -6.89% after moving up more than double digits this week. A controversial practice that has brought in billions of dollars to brokers and high-frequency trading firms is in the crosshairs of the Securities and Exchange Commission, and could be eliminated entirely. In an interview with Barron’s on Monday, SEC Chairman Gary Gensler said that a full ban of payment for order flow is “on the table.” Payment for order flow is a practice where brokers send trade orders to market makers that execute those trades in return for a portion of the profits.  Gensler says the practice has “an inherent conflict of interest.” Market makers make a small spread on each trade, but that’s not all they get, he said.

Shares of Seanergy Maritime Holdings Corp. (NASDAQ: SHIP closed at $1.29, +2.38% the high of the day.  SHIP, the only pure-play Capesize ship-owner publicly listed in the US, recently announced that its Board of Directors has authorized a share repurchase plan. Under the Plan, the Company may repurchase up to $17 million of its outstanding common shares, representing approximately 10% of the Company’s market capitalization as of August 10, 2021. 

VP WATCHLIST HIGHLIGHTS

Our complete VP Watchlist is a list that we believe deserves consideration for short term and long term portfolio adds that include Apple, Tesla, Disney & 8 other names currently. The dedicated pages for each of these companies will enable you to stay informed and learn more about these companies daily. Please review few of the updates on a few of the VP Watchlist companies below:


  • Shares of VP Watchlist stock, INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease including Alzheimer’s disease, closed at $22.60, +12.83% after hitting $23.46 in intraday trading on 598.8k if trading volume. A short squeeze of some manner is in rumored to be in play for this low float biotech company that was refinanced via an equity offering at $22.
    • On Wednesday, Aug. 4th, INmune Bio, Inc. reported its financial results for the second quarter ended June 30, 2021 and provided a business update. Raymond J Tesi, M.D., CEO/CMO of INmuneBio (INMB) stated, “We continue our planning and setup for a Phase 2 clinical trial of our lead candidate, XPRO™ (Xpro1595™), in patients with mild Alzheimer’s disease, which we plan to initiate by year-end. We have already demonstrated that XPRO™ can reduce neuroinflammation and decreases biomarkers of neurodegeneration and improve synaptic function. If successful in Phase 2, we believe XPRO™ has the potential to be among the most significant advancements in the treatment of Alzheimer’s Disease (AD) and other neurodegenerative diseases in many years. At the Alzheimer’s Association International Conference last week, we introduced a new biomarker – Apparent Fiber Density (AFD), a measure of axonal integrity measured by MRI. XPRO™ increases AFD in patients receiving 1mg/kg/week. We believe the novel non-invasive white matter analytics of white matter free water and apparent fiber density will be very useful in the development of XPRO™ in AD, Treatment Resistant Depression (TRD) and the many other CNS indications we hope to attack in the future. Last month, we treated the first patient in the first Phase 1 clinical trial of our NK cell priming platform, INKmune, in high-risk myelodysplastic syndrome (MDS). We are calling INKmune a pseudokine because, in vitro, it converts the resting NK cells into memory-like NK cells that can kill cancer cells as well or better than NK cells treated cytokines such as IL-12, IL-15 and IL-18 alone or in combination.”
    • On July 26th, INmune Bio announced the design of its upcoming Phase 2 clinical trial of XProTM in patients diagnosed with mild Alzheimer’s disease (AD) at AAIC. The announcement was accompanied by the release of additional biomarker data from the Phase 1b AD trial that shows improvement in white matter (myelinated axons) that degenerate in AD patients. READ MORE. 
 

  • Shares of Fate Therapeutics (FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, closed at $71.74/share, -1.24%. The 52-wk high is $121.16. 
    •  On August 19th, FATE highlighted positive interim clinical data from the Company’s FT516 and FT596 programs for patients with relapsed / refractory B-cell lymphoma. FT516 is the Company’s universal, off-the-shelf natural killer (NK) cell product candidate derived from a clonal master induced pluripotent stem cell (iPSC) line engineered with a novel high-affinity, non-cleavable CD16 (hnCD16) Fc receptor, which is designed to maximize antibody-dependent cellular cytotoxicity (ADCC), a potent anti-tumor mechanism by which NK cells recognize, bind and kill antibody-coated cancer cells. The Company’s FT596 program incorporates both the hnCD16 Fc receptor and a chimeric antigen receptor (CAR) targeting CD19, which is designed to enable multi-antigen targeting of tumor cells, as well as an IL-15 receptor fusion (IL-15RF) to enhance NK cell activity and survival.
    • On August 4th, Fate reported business highlights and financial results for the second quarter ended June 30, 2021. Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics stated, “We are very pleased with the early clinical safety and activity we have observed with our off-the-shelf, iPSC-derived NK cell programs in relapsed / refractory lymphoma and acute myeloid leukemia, where interim Phase 1 data indicate FT516 and FT538 are well tolerated and can deliver complete responses for patients. We look forward to sharing additional clinical data from our FT516 and FT596 programs in B-cell lymphoma at our upcoming investor event. Additionally, treatment of the first patient with FT819, the first-ever iPSC-derived T-cell therapy to undergo clinical investigation, is a landmark achievement and further demonstrates the Company’s leadership in off-the-shelf, iPSC-derived cell therapy and the versatility of its proprietary iPSC Product Platform.”
    • On Aug. 2 Fate announced that the first patient has been treated with FT819, an off-the-shelf chimeric antigen receptor (CAR) T-cell therapy targeting CD19+ malignancies. FT819 is the first-ever CAR T-cell therapy derived from a clonal master induced pluripotent stem cell (iPSC) line, a renewable cell source that enables mass production of high quality, allogeneic CAR T cells with greater product consistency, off-the-shelf availability, and broader patient accessibility. FT819 is engineered with several first-of-kind features designed to improve the safety and efficacy of CAR T-cell therapy.


  • INVO Bioscience (NASDAQ: INVO) is a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System. Shares of INVO closed at $3.81, but is trading up to $4 in the aftermarkets. 
    • On August 16th, INVO announced their financial and operating results for the second quarter ended June 30, 2021 and provided a business update. Steve Shum , CEO of INVO stated. “Our team made excellent progress during the second quarter of 2021 toward our key objectives, headlined by last week’s official opening of our first INVO Center practice in Birmingham, AlabamaWe feel INVO is now well positioned for success based on the following core foundational elements developed over the past 2 years. We believe there is a substantial underserved patient population with infertility challenges and a real need to expand access to treatment. In our opinion, this is a multi-billion-dollar market expansion opportunity, and INVOcell is well positioned to address the unmet medical need.”
    • On Aug.2, INVO announced the Company’s first Joint Venture INVO Center practice in the United States, based in Birmingham, Alabama, was officially opening on August 9, 2021. Dr. Hammond commented, “With the opening of the country’s first INVOcell medical practice, we are advancing a core mission towards improving access to advanced fertility services for the many patients who would otherwise never have the opportunity. To date, we have already received numerous advanced inquiries via word of mouth and have dozens of patients scheduled for initial patient consultations who are eager to proceed with treatment. As we officially open the center next week, we expect to accelerate our marketing programs with the help of the INVO marketing team to enhance overall patient awareness around Innovative Fertility Specialists, An INVO Center.”
    • Over the past 40+ years, since the first IVF baby was born, the fertility market has grown into a $20+ billion global industry. Here in the U.S., according to the most recent 2019 CDC data, approximately 330,000 IVF cycles were performed across 448 clinics, which implies a roughly $5 billion domestic marketplace. However, this represents only a small portion of the actual market as approximately 90% of infertile couples go untreated each year. There are some real challenges with bridging the gap of treating the volume of patients that need care. Patient affordability and lack of insurance coverage is often the most discussed dynamic, but that is only one part of the challenge. We believe that there is an equal or even greater challenge related to capacity limitations in the industry given the relatively small number of IVF clinics and limited human resources available which are typically only available in major metropolitan areas. We believe that INVO Biosceince’s INVOcell, without the need of expensive lab build outs, can bring much needed capacity additions and access to the market beyond the major metropolitan areas at a more affordable price.


  • Shares of VP Watchlist firm, Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, closed at $3.53, -5.36%  on 6.44M shares of trading volume after reaching a high of $3.75 in intraday trading. 
    • On Aug 13th, Atossa announced financial results for the fiscal quarter ended June 30, 2021, and provided an update on recent company developments. “We continue to experience encouraging progress in our MBD and COVID-19 programs, with new regulatory approvals being granted in Sweden for a Phase 2 trial in MBD and authorization in Australia to commence a Phase 2 study of AT-H201 for respiratory illness associated with COVID-19. In the meantime, we continue to enjoy a strong balance sheet, which we have significantly expanded over the last three quarters and will facilitate our development plans over the near term. As we actively explore the possibility for strategic expansion into other areas where we might see near-term milestones and results, we also urge all of our shareholders to exercise their right to vote at our special stockholder’s meeting on September 7, 2021. We urge a vote in favor of the proposal to increase authorized shares, which will provide the Company with the flexibility to issue shares as part of these potential acquisitions, collaborations and partnerships, a common strategy successful biotech companies seeking to grow shareholder value employ in order to create a more attractive opportunity for all. We look forward to continuing to update our stockholders on these opportunities as they develop,” stated Dr. Steven Quay, Atossa’s President and Chief Executive Officer.


  • Shares of VP Watchlist stock, InMed Pharmaceuticals, Inc. (NASDAQ: INM), a leading clinical-stage pharmaceutical company developing cannabinoid-based drug candidates for high unmet medical needs and IntegraSyn, a proprietary and cost effective manufacturing approach for synthesized rare cannabinoids, closed trading at $2.35, after reaching $2.4818 during intraday.  The 52-wk range is $2.031 – $8.94. 
  • On July 9th, Roth Capital Partners analyst Scott Henry, CFA issued an update report with a BUY Rating titled, “INM: Favorable Take on BayMedica LOI” that includes a $11.50 12-Month Price target.
    • On Aug.9th, I published an informative story titled “A Recent Discussion With The CEO of InMed Pharmaceuticals (NASDAQ: INM) Regarding Development Of IntegraSyn™, A Proprietary Manufacturing Approach To Economically Produce Pharmaceutical-Grade Cannabinoids” PLEASE READ NOW.
    • On July 2nd, InMed announced that it had closed the previously announced private placement and after deducting the placement agent fees and estimated offering expenses payable by the Company, the Company received net proceeds of approximately US$11 million. H.C. Wainwright & Co. acted as the exclusive placement agent for the private placement. Under the terms of the private placement, an aggregate of 4,036,327 common shares (or common share equivalents in lieu thereof) and warrants to purchase up to an aggregate of 4,036,327 common shares were purchased, at an effective purchase price of US$2.973 per common share (or common stock equivalent in lieu thereof) and associated warrant. The warrants have an exercise price of US$2.848 per share, are exercisable immediately and have a term of five years. InMed intends to use the net proceeds from the offering to continue pipeline development, advance business development activities and for general working capital purposes.
    • On June 29th, INM announced that it has entered into a non-binding letter of intent (the “LOI”) to acquire BayMedica Inc. (“BayMedica”), a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids. BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable, and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is currently planning additional rare cannabinoid launches for the coming year. In addition to their manufacturing and commercial activities in the health and wellness arena, BayMedica is researching cannabinoid analogs as potential drug candidates for pharmaceutical purposes. Those BayMedica proprietary compounds are based upon the structures of naturally-occurring cannabinoids and are designed to either augment the potential therapeutic effect against specific diseases or enhance product safety, or both.

Economic Reports

  • On Monday, the macroeconomic schedule delivered  the Pending Home Sales report that confirmed a drop by 1.8% month/month in July. 

Investing & Inspiration

  1. “By failing to prepare, you are preparing to fail.” – Benjamin Franklin
  2. “We cannot solve our problems with the same thinking we used when we created them.” – Albert Einstein
  3. “When you’re an investor, you can look at the quantitative and qualitative elements of an investment, but there’s a third aspect: What you feel in your gut.” – Kevin O’Leary
  4. “Set your course by the stars, not by the lights of every passing ship.” – Omar N. Bradley
  5. “Do not take life too seriously. You will never get out of it alive.” – Elbert Hubbard
  6. “Education is not only a ladder of opportunity, but it is also an investment in our future.” – Ed Markey 
  7. “Every good painter paints what he is.” – Jackson Pollock
  8. “If you believe in yourself and have dedication and pride – and never quit, you’ll be a winner. The price of victory is high but so are the rewards.” – Bear Bryant
  9. “Your mindset matters. It affects everything – from the business and investment decisions you make, to the way you raise your children, to your stress levels and overall well-being.” – Peter Diamandis
  10. “You cannot have a positive life and a negative mind.” – Joyce Meyer 
  11. “Like wildebeest and zebra migration across the Serengeti, investment managers and consultants, too, have a habit of running together and, every now and then, changing direction.” – Sanjaya Baru
  12. “If people are anything but enthusiastic about the information or ideas that they’re sharing, they’re either not that invested in what they’re doing – or they’re not communicating that investment effectively.” – Ana Kasparian 
  13. “Life consists not in holding good cards but in playing those you hold well.” – Josh Billings 
  14. “Friend, there’s no greater investment in life than in being a people builder. Relationships are more important than our accomplishments.” – Joel Osteen
  15. “It’s only natural that the heavy users help contribute to the investment to keep the Web healthy. That is the most important concept of net neutrality.” – Lowell McAdam
  16. “The more sand that has escaped from the hourglass of our life, the clearer we should see through it.” – Jean Paul 
  17. “Eliminate emotion from your investment program.” -John C. Bogle

  18. “Modern medical advances have helped millions of people live longer, healthier lives. We owe these improvements to decades of investment in medical research.” – Ike Skelton
  19. “In every investment, before I get involved or invest, I always see what the mindset of the founder, the CEO, is.” – Zaza Pachulia
  20. “An investment said to have an 80% chance of success sounds far more attractive than one with a 20% chance of failure. The mind can’t easily recognize that they are the same.” – Daniel Kahneman
  21. “The return on investment in global health is tremendous, and the biggest bang for the buck comes from vaccines. Vaccines are among the most successful and cost-effective health investments in history.” – Seth Berkley
  22. “Few things in the world are more powerful than a positive push. A smile. A world of optimism and hope. A ‘you can do it’ when things are tough.” – Richard M. DeVos
  23. “To be yourself in a world that is constantly trying to make you something else is the greatest accomplishment.” – Ralph Waldo Emerson
  24. “We all have dreams. But in order to make dreams come into reality, it takes an awful lot of determination, dedication, self-discipline, and effort.”  – Jesse Owens
  25. “The pessimist complains about the wind; the optimist expects it to change; the realist adjusts the sails.” – William Arthur Ward- American Writer, Born 1921
  26. “Once you replace negative thoughts with positive ones, you’ll start having positive results.” – Willie Nelson
  27. “The secret of your future is hidden in your daily routine.” – Mike Murdock
  28.  “If somebody puts you down or criticizes you, just keep on believing in yourself and turn it into something positive.” – Leah LaBelle
  29. “Opportunity is missed by most people because it is dressed in overalls and looks like work”. -Thomas A. Edison
  30. “Education is not only a ladder of opportunity, but it is also an investment in our future.” – Ed Markey
  31. “Human behavior flows from three main sources: desire, emotion, and knowledge.” – Plato

  32. “We are what our thoughts have made us; so take care about what you think. Words are secondary. Thoughts live; they travel far.” – Swami Vivekananda
  33. “Success is not final, failure is not fatal: it is the courage to continue that counts.” – Winston Churchill
  34. “If you don’t know where you are going, any road will get you there.” – Lewis Carroll

  35. “Don’t worry about being a star, worry about doing good work, and all that will come to you.” – Ice Cube

  36. “It is not in the stars to hold our destiny but in ourselves.” – William Shakespeare

  37. Prediction is very difficult, especially if it’s about the future.” – Niels Bohr (Danish Physicist)
  38. “It is indeed true that the stock market can forecast the business cycle.” -Paul Samuelson

  39. “The wisest rule in investment is: when others are selling, buy. When others are buying, sell. Usually, of course, we do the opposite. When everyone else is buying, we assume they know something we don’t, so we buy. Then people start selling, panic sets in, and we sell too.” – Jonathan Sacks

  40. “What lies behind you and what lies in front of you, pales in comparison to what lies inside of you.” – Ralph Waldo Emerson
  41. “Each new generation born is in effect an invasion of civilization by little barbarians, who must be civilized before it is too late.” – Thomas Sowell
  42. “Life is 10% what happens to you and 90% how you react to it.” – Charles R. Swindoll
  43. “The truth is you don’t know what is going to happen tomorrow. Life is a crazy ride, and nothing is guaranteed.” – Eminem
  44. “View health as an investment, not an expense.” – John Quelch

  45. “Opportunity does not knock, it presents itself when you beat down the door.” – Kyle Chandler

  46. “If you don’t know where you are going, any road will get you there.” – Lewis Carroll
  47. “Once you replace negative thoughts with positive ones, you’ll start having positive results.” – Willie Nelson
  48. “That which does not kill us makes us stronger.” – Friedrich Nietzsche
  49. “Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” – Marie Curie
  50. “A problem is a chance for you to do your best.”–  Duke Ellington
  51. “The best way to predict the future is to create it.” -Peter Drucker
  52. “I’m involved in the stock market, which is fun and, sometimes, very painful.” – Regis Philbin
  53. “Who owns the future? This is the question at the heart of every stock market.” – John Landgraf
  54. “One of the funny things about the stock market is that every time one person buys, another sells, and both think they are astute.” – William Feather
  55. While I’m sure some millennials are concerned with the ethical issues involved in mining for diamonds, the main reason they steer clear of the gems is because, well, they’re a dumb investment.” – Ana Kasparian
  56. “The wisest rule in investment is: when others are selling, buy. When others are buying, sell. Usually, of course, we do the opposite. When everyone else is buying, we assume they know something we don’t, so we buy. Then people start selling, panic sets in, and we sell too.” – Jonathan Sack
  57. “We must shift our thinking away from short-term gain toward long-term investment and sustainability, and always have the next generations in mind with every decision we make.” –  Deb Haaland
  58. “The only way to have a friend is to be one.” –  Ralph Waldo Emerson
  59. “If you believe in yourself and have dedication and pride – and never quit, you’ll be a winner. The price of victory is high but so are the rewards.” – Bear Bryant
  60. “Investing in women’s lives is an investment in sustainable development, in human rights, in future generations – and consequently in our own long-term national interests.” -Liya Kebede

  61. “Success is not final, failure is not fatal: it is the courage to continue that counts.”– Winston Churchill
  62. “Our greatest glory is not in never falling, but in rising every time we fall.” – Confucius

  63. “Give me a lever long enough and a fulcrum on which to place it, and I shall move the world.” – Archimedes
  64. “Who controls the past controls the future. Who controls the present controls the past.” – George Orwell
  65. “If you get up in the morning and think the future is going to be better, it is a bright day. Otherwise, it’s not.” – Elon Musk
  66. “The pessimist complains about the wind; the optimist expects it to change; the realist adjusts the sails.” – William Arthur Ward
  67. “Start where you are. Use what you have. Do what you can.” – Arthur Ashe
  68. “Netflix, Amazon, iTunes – whatever platforms emerge – we are looking at as having the same potential that home video had for the movie business. Which means there are entirely new opportunities to monetize our capital investment in content and do so in ways that work for distributors, for consumers and for creators.” – Bob Iger
  69. “When you have no one to answer to, vendetta as investment strategy is as legitimate as anything.” – Carl Icahn

  70. “No other investment yields as great a return as the investment in education. An educated workforce is the foundation of every community and the future of every economy.” – Brad Henry
  71. “In my view, the biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital. Not only is the mere drop in stock prices not risk, but it is an opportunity. Where else do you look for cheap stocks?” – Li Lu
  72. “Modern medical advances have helped millions of people live longer, healthier lives.

  73. We owe these improvements to decades of investment in medical research.”– Ike Skelton

  74. “Stock market goes up or down, and you can’t adjust your portfolio based on the whims of the market, so you have to have a strategy in a position and stay true to that strategy and not pay attention to noise that could surround any particular investment.” – John Paulson

  75. “Your mindset matters. It affects everything – from the business and investment decisions you make, to the way you raise your children, to your stress levels and overall well-being.” – Peter Diamandis
  76. “Inflation destroys savings, impedes planning, and discourages investment. That means less productivity and a lower standard of living.” – Kevin Brady
  77. “Bitcoin, in the short or even long term, may turn out be a good investment in the same way that anything that is rare can be considered valuable. Like baseball cards. Or a Picasso.” – Andrew Ross Sorkin
  78. “I think you have to learn that there’s a company behind every stock and there’s only one real reason why stocks go up. Companies go from doing poorly to doing well or small companies grow to large companies.” – Peter Lynch
  79. “Historically, there has been a bull market in the commodities every 20 or 30 years.” – Jim Rogers
  80. “The markets generally are unpredictable, so that one has to have different scenarios. The idea that you can actually predict what’s going to happen contradicts my way of looking at the market.” – George Soros
  81. “Stop trying to predict the direction of the stock market, the economy or the elections.” – Warren Buffett
  82. “An important key to investing is to remember that stocks are not lottery tickets.” – Peter Lynch
  83. “Learn everyday, but especially from the experiences of others. It’s cheaper!” – John Bogle
  84. “When purchasing depressed stock in troubled companies, seek out the ones with the superior financial positions and avoid the ones with loads of bank debt.” – Peter Lynch
  85. “No stock price is too low for bears or too high for bulls.” – John F. Heerdink, Jr.
  86. “Investment is most successful when it is most businesslike.” – Ben Graham

  87. “Value stocks are about as exciting as watching grass grow, but have you ever noticed just how much your grass grows in a week?” – Christopher Browne

  88. “Even the intelligent investor is likely to need considerable willpower to keep from following the crowd.” – Benjamin Graham
  89. “Individual who cannot master their emotions are ill-suited to profit from the investment process.” – Benjamin Graham
  90. “I made my first investment at age eleven. I was wasting my life until then.” – Warren Buffet
  91. “I don’t look to jump over seven-foot bars; I look around for one-foot bars that I can step over.” — Warren Buffett
  92. “There are only three measurements that tell you nearly everything you need to know about your organization’s overall performance: employee engagement, customer satisfaction, and cash flow. It goes without saying that no company, small or large, can win over the long run without energized employees who believe in the mission and understand how to achieve it.” – Jack Welch, former CEO of GE
  93. “Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble” ― Warren Buffett
  94. “If you buy things you do not need, soon you will have to sell things you need.” – Warren Buffet
  95. “How many millionaires do you know who have become wealthy by investing in savings accounts? I rest my case.” — Robert G. Allen
  96. “It’s far better to buy a wonderful company at a fair price, than a fair company at a wonderful price.” – Warren Buffett
  97. “A market downturn doesn’t bother us. It is an opportunity to increase our ownership of great companies with great management at good prices.” — Warren Buffett
  98. “Every once in a while, the market does something so stupid it takes your breath away.” — Jim Cramer
  99. “The person who starts simply with the idea of getting rich won’t succeed; you must have a larger ambition.” — John D. Rockefeller
  100. “Know what you own, and know why you own it.” – Peter Lynch
  101. “Although it’s easy to forget sometimes, a share is not a lottery ticket… it’s part ownership of a business.” – Peter Lynch
  102. “Wise spending is part of wise investing. And it’s never too late to start.” – Rhonda Katz
  103. “Invest for the long haul. Don’t get too greedy and don’t get too scared.” – Shelby M.C. Davis

  104. “Fear incites human action far more urgently than does the impressive weight of historical evidence.”
    -Jeremy Siegel
  105. “With a good perspective on history, we can have a better understanding of the past and present, and thus a clear vision of the future.” — Carlos Slim Helu
  106. “If we like a business, we’re going to buy as much of it as we can and keep it as long as we can. And when we change our mind, we don’t take half measures.” – Warren Buffett
  107. “The most contrarian thing of all is not to oppose the crowd but to think for yourself.” — Peter Thiel

  108. “Never depend on a single income, make an investment to create a second source.” Warren Buffet

  109. Games are won by players who focus on the playing field –- not by those whose eyes are glued to the scoreboard.”
    ― Warren Buffett
  110. “The key to making money in stocks is not to get scared out of them.” – Peter Lynch
  111. “Courage taught me no matter how bad a crisis gets … any sound investment will eventually pay off.” — Carlos Slim Helu
  112. “Investing puts money to work. The only reason to save money is to invest it.” – Grant Cardone
  113. “As time goes on, I get more and more convinced that the right method of investment is to put fairly large sums into enterprises which one thinks one knows something about and in the management of which one thoroughly believes.” — John Maynard Keynes
  114. “Given a 10% chance of a 100 times payoff, you should take that bet every time.” — Jeff Bezos
  115. “Money is always eager and ready to work for anyone who is ready to employ it.” ― Idowu Koyenikan
  116. The secret to investing is to figure out the value of something – and then pay a lot less.” – Joel Greenblatt
  117. “We don’t have an analytical advantage, we just look in the right place.” – Seth Klarman
  118. “Men, it has been well said, think in herds. It will be seen that they go mad in herds, while they only recover their senses slowly, and one by one.” – Charles Mackay
  119. “It’s not whether you’re right or wrong that’s important, but how much money you make when you’re right and how much you lose when you’re wrong.” – George Soros
  120. “No Price is too low for a bear or too high for a bull.” — Anonymous
  121. “Investment is an asset or item that is purchased with the hope that it will generate income or appreciate in the future.” Anonymous
  122. “Behind every stock is a company. Find out what it’s doing.” — Peter Lynch
  123. “Wise spending is part of wise investing. And it’s never too late to start.” –Rhonda Katz
  124. “It amazes me how people are often more willing to act based on little or no data than to use data that is a challenge to assemble.” ― Robert Shiller
  125. “A bull market is like sex. It feels best just before it ends.” — Barton Biggs
  126. “The investor’s chief problem — even his worst enemy — is likely to be himself.” — Benjamin Graham
  127. “No profession requires more hard work, intelligence, patience, and mental discipline than successful speculation.” – Robert Rhea
  128. “Money is like a sixth sense – and you can’t make use of the other five without it.” – William Somerset Maugham
  129. “Compound interest is the eighth wonder of the world. He who understands it, earns it. He who doesn’t, pays it.” — Albert Einstein
  130. “Never count on making a good sale. Have the purchase price be so attractive that even a mediocre sale gives good results” — Warren Buffett
  131. “The stock market is a device for transferring money from the impatient to the patient.” – Warren Buffett
  132. “Thousands of experts study overbought indicators, head-and-shoulder patterns, put-call ratios, the Fed’s policy on money supply…and they can’t predict markets with any useful consistency, any more than the gizzard squeezers could tell the Roman emperors when the Huns would attack.” – Peter Lynch
  133. “Investing puts money to work. The only reason to save money is to invest it.” – Grant Cardone
  134. “You cannot save time for your future use however you can invest time for your future.” – John F. Heerdink, Jr. 
  135. “Know what you own, and know why you own it.” – Peter Lynch
  136. “Liquidity is only there when you don’t need it.” -Old Proverb
  137. “If you want to be a millionaire, start with a billion dollars and launch a new airline.” – Richard Branson
  138. “Fear incites human action far more urgently than does the impressive weight of historical evidence.” – Jeremy Siegel
  139. “In investing, what is comfortable is rarely profitable.” – Robert Arnott
  140. “Spend each day trying to be a little wiser than you were when you woke up.” – Charlie Munger
  141. “The entrance strategy is actually more important than the exit strategy.” – Edward Lampert
  142. “The rivers don’t drink their own water; Trees don’t eat their own fruits. The sun does not shine for itself, And flowers do not spread their fragrance For themselves. Living for others is a rule of nature” – Pope Francis
  143. “It is impossible to produce superior performance unless you do something different from the majority.” – John Templeton
  144. “An investment in knowledge pays the best interest.” – Benjamin Franklin.
  145. I believe the returns on investment in the poor are just as exciting as successes achieved in the business arena, and they are even more meaningful!” -Bill Gates
  146. “Every portfolio benefits from bonds; they provide a cushion when the stock market hits a rough patch. But avoiding stocks completely could mean your investment won’t grow any faster than the rate of inflation.” – Suze Orman
  147. “The tax on capital gains directly affects investment decisions, the mobility, and flow of risk capital… the ease or difficulty experienced by new ventures in obtaining capital, and thereby the strength and potential for growth in the economy.” – John F. Kennedy
  148. “If all the economists were laid end to end, they’d never reach a conclusion. -George Bernard Shaw
  149. “There are old traders and there are bold traders, but there are very few old, bold traders.”-Ed Seykota
  150. “Let this scenario play out on its own, in its own fashion. As you watch it unfold, you will soon be grateful that you choose the peaceful path. Remember — those who live by the sword, die by the sword.”
  151. “As long as you enjoy investing, you’ll be willing to do the homework and stay in the game.” -Jim Cramer
  152. “I rarely think the market is right. I believe non-dividend stocks aren’t much more than baseball cards. They are worth what you can convince someone to pay for it.” -Mark Cuban
  153. Michael Marcus taught me one other thing that is absolutely critical: You have to be willing to make mistakes regularly; there is nothing wrong with it. Michael taught me about making your best judgment, being wrong, making your next best judgment, being wrong, making your third best judgment, and then doubling your money.” -Bruce Kovner
  154. “The policy of being too cautious is the greatest risk of all.” -Jawaharlal Nehru
  155. “The only true test of whether a stock is “cheap” or “high” is not its current price in relation to some former price, no matter how accustomed we may have become to that former price, but whether the company’s fundamentals are significantly more or less favorable than the current financial-community appraisal of that stock.” -Philip Fisher
  156. “I learned to avoid trying to catch up or double up to recoup losses. I also learned that a certain amount of loss will affect your judgment, so you have to put some time between that loss and the next trade.” -Richard Dennis
  157. “The four most dangerous words in investing are: ‘this time it’s different.” -Sir John Templeton
  158. “Money doesn’t make you happy. I now have $50 million but I was just as happy when I had $48 million.” -Arnold Schwarzenegger

Videos

Please consider viewing these interesting videos: